| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
REGULAR ARTICLES |
Department of Nephrology and Hypertension, University Hospital Utrecht, The Netherlands.
Correspondence to Dr. Branko Braam, Department of Nephrology and Hypertension, Room F03.226, University Hospital Utrecht, P.O. Box 85500, 3508 GA The Netherlands. Phone: +31 30 250 7329; Fax: +31 30 251 0964; E-mail: BrBraam{at}Knoware.nl
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
In our laboratory, combined peritubular infusion of angiotensin II (AngII) and the NO synthesis inhibitor NG -nitro-L-arginine (L-NNA) led to extremely high TGF responses (10). Because the TGF system participates in RBF autoregulation, these enhanced responses during inhibition of NO formation could well lead to increased efficiency of RBF autoregulation, in particular under conditions of increased circulating AngII levels. RBF in the nonclipped kidney of two-kidney, one-clip (2K1C) Goldblatt hypertensive rats has been shown to be highly sensitive to NO inhibition (11,12). Furthermore, we have recently demonstrated that the intrarenal infusion rate of sodium nitroprusside needed to restore renal function to base-line after blockade of NO formation is much higher in the contralateral kidney of 2K1C rats than in sham-operated controls. TGF responses in this kidney are extremely dependent on NO in this model (11), suggesting high levels of ambient NO. Enhanced production and systemic delivery of AngII by the ipsilateral kidney forms the basic endocrine disturbance (13,14). Nevertheless, the reported defect in autoregulation of the contralateral kidney (15) is not compatible with actions of AngII (16).
The central hypothesis of the present investigation is that an adaptive increase of the actions of NO maximizes RBF at the cost of impaired autoregulation in the contralateral kidney of renovascular hypertensive rats. To address this hypothesis, the characteristics of renal autoregulation were studied in kidneys of normotensive rats and in the nonclipped kidney of 2K1C hypertensive rats before and during systemic infusion of the NO synthase (NOS) inhibitor L-NNA. A new mathematical analysis was developed and applied to identify the lower limit of autoregulation and to analyze the efficiency of renal autoregulation.
| Materials and Methods |
|---|
|
|
|---|
Surgical Procedure and Infusions
On the day of the experiment, the animals were anesthetized with Inactin
(110 mg/kg body wt intraperitoneally) and placed on a servo-controlled
surgical table that maintained rectal temperature at 37°C. After
intubation of the trachea, a catheter was placed into the left jugular vein
(PE50) for infusion of solutions, and a second catheter (PE10) was introduced
for bolus injections. The femoral artery was cannulated (PE50) to measure RPP
and to collect blood samples. The left kidney was exposed through a flank
incision, freed from surrounding tissue, and placed into a plastic holder; the
left ureter was cannulated with PE-10 tubing. A 1RB ultrasonic flow probe was
placed around the left renal artery and connected to a transit time blood flow
meter (model T206; Transonics, Ithaca, NY). A sling was placed around the
aorta between the renal arteries to enable reduction of the left RPP.
All animals received an intravenous infusion of a 150 mM NaCl solution containing 6% bovine serum albumin (Sigma Chemical Co., St. Louis, MO) at a rate of 10 µl/min per 100 g body wt. After surgery, the infusion was switched to a 150 mM NaCl solution with 1% bovine serum albumin at the same infusion rate. This infusion was maintained throughout the experiment. Experimental compounds were added to this standard solution. A 60-min equilibration period was observed before the start of the measurements. At the end of each experiment, the left kidney (and in the 2K1C rats also the right kidney) was removed, blotted dry, and weighed.
In normotensive rats (L-NNA, n = 9), an autoregulation curve was obtained under baseline conditions. Then, a bolus injection of L-NNA (1.5 mg/kg) was injected and an infusion of 10 µg/kg per min L-NNA was started. After equilibration at a new level of mean arterial pressure (MAP) and RBF, the autoregulation curve was repeated. In the 2K1C animals (n = 9), the protocol was identical. In previous experiments, we have shown that this infusion scheme leads to a stable increase in MAP and a stable reduction of RBF (19).
Autoregulation Protocol
First, a baseline measurement of RBF and MAP was obtained. Then, RPP was
reduced in random order to 60, 70, 80, 90, 100, 110, 120, and, if applicable,
to 130, 140, 150, and 160 mmHg by adjusting the sling around the aorta. After
each reduction in RPP, the RBF was recorded for at least 20 to 30 s. After
each measurement at reduced RPP, the sling was released and RPP and RBF were
allowed to return to baseline values. After switching the infusion, at least
30 min was allowed to pass before another curve was recorded.
Statistical Analyses
The pressure system and the flow meter were connected to a personal
computer by an analog-to-digital converter with a sample frequency of 3 Hz.
The RBF autoregulation curve was generated by extrapolating the values of RBF
at different levels of RPP by linear regression to exact values of 60, 70, 80,
90, 100, 120, and, if possible, to 130, 140, 150 and 160 mmHg. Renal vascular
resistance (RVR) was calculated as RPP divided by RBF. Data are expressed as
mean ± SEM. The lower limit of autoregulation and the degree of
compensation were calculated as outlined in the appendix. The degree of
compensation is a measure of autoregulatory efficiency. In case there is no
change in RBF upon a decrease in RPP, the value is 100%; in case the change in
RBF equals the change as expected if the vascular bed would not autoregulate,
the value is 0. Data from control rats and 2K1C rats were compared with
two-way ANOVA and two-way ANOVA for repeated measurements. If a variance ratio
reached statistical significance, the Student-Newman-Keuls test was performed
as post hoc test. In case the data were not normally distributed, a
two-way repeated-measures ANOVA on ranks was used; this is indicated in the
Results section.
A new method was developed to estimate the lower limit of autoregulation. The raw data of the autoregulation curves were subjected to nonlinear regression analysis using the logistic equation. The lower limit was then defined as the perfusion pressure, where the third derivative of the fitted curve was 0, which mathematically defines the shoulder in a sigmoidal curve. This method avoids the error introduced by the limited number of perfusion pressures at which RBF is evaluated. Also, if one uses an arbitrary decrease in RBF, one will incorrectly identify the lower limit of autoregulation in curves that show poor autoregulation. The exact mathematical derivation of the lower limit is outlined in the Appendix, and an example of a curve and its derivatives is depicted in Figure 1. The lower limit of autoregulation was also determined manually in all curves by six members of the department; the intercept of the lines drawn through the lower part and the upper part of the autoregulation curve was used as lower limit. It should be emphasized that the interpreters were given a brief instruction and that the curves were coded.
|
| Results |
|---|
|
|
|---|
|
|
Autoregulation Curves: RBF and RVR
Control animals demonstrated autoregulation of RBF before the infusion of
L-NNA (Figure 3A). During the
infusion of L-NNA, autoregulation was preserved, as RBF was lower at all RPP
(Figure 3A). In the
contralateral kidney of 2K1C rats, autoregulation under baseline conditions
did not show such a clear plateau as observed in the control animals
(Figure 3A). When expressed as
percentage of control RBF (Figure
3B), this is even more pronounced. L-NNA infusion again decreased
RBF at all perfusion pressures studied. Also, a plateau could now be observed
in the autoregulation curves. It should be emphasized that the average curves
presented in the figure underestimate the power of autoregulation of each
individual rat, as not all lower limits of autoregulation are exactly
similar.
|
Autoregulation Curves: Lower Limit and Efficiency of RBF
Autoregulation
The lower limit was calculated from the fitted sigmoidal curve and its
third derivative as detailed in the Appendix. Under baseline conditions, the
lower limit was 78 ± 3 (n = 9) mmHg in the normotensive rats.
During infusion of L-NNA, the lower limit decreased to 70 ± 2 mmHg, a
value not significantly different from baseline
(Figure 4). The degree of
compensation under baseline conditions was not significantly different from
the values observed during L-NNA infusion in the normotensive rats
(Figure 5), except at a
pressure below 90 mmHg. Nevertheless, the entire curve was shifted upward,
indicating an overall tendency for better autoregulation during NO
blockade.
|
|
In 2K1C hypertensive animals, the lower limit of autoregulation under baseline conditions was slightly higher than the values observed in the normotensive animals (85 ± 3 mmHg; n = 9; NS) (Figure 6). Under conditions of blockade of NO synthesis, however, the lower limit decreased significantly to 72 ± 5 mmHg (P < 0.05 versus baseline). At lower perfusion pressures, the degree of compensation was significantly lower in the 2K1C rats compared to the control animals. Also, the degree of compensation was less under baseline conditions compared to L-NNA infusion in the 2K1C animals (Figure 5). Thus, the contralateral kidney of 2K1C rats displayed impaired autoregulation under baseline conditions. A decrease in the lower limit and an increase in the efficiency of autoregulation followed infusion of L-NNA.
|
Manual Estimates of the Lower Limit of Autoregulation
Manually determined (as determined by taking the average for each curve of
the six interpretations), the lower limit was 95 ± 3 mmHg under
baseline conditions in left kidneys of the normotensive rats and 104 ±
3 mmHg in the nonclipped kidneys of the 2K1C rats. During L-NNA infusion, the
lower limit decreased to 88 ± 3 and 93 ± 4 mmHg in normotensive
and 2K1C rats, respectively. This decrease was only significant in the 2K1C
rats.
The differences between the estimates of the six interpreters was quite high: On average, the difference between the highest and lowest estimate was 10 ± 2 mmHg under baseline conditions and 13 ± 4 mmHg during L-NNA infusion in the normotensive rats. In the 2K1C rats, these values were even higher and averaged 35 ± 3 and 30 ± 5 mmHg. This simple evaluation reveals considerable error in manual interpretation of the curves.
| Discussion |
|---|
|
|
|---|
Previous studies have yielded contrasting results as to whether NO is involved in autoregulation of RBF in normotensive animals. In a study on the interaction of NO and prostaglandins on the RBF and papillary blood flow, Ortíz et al. demonstrated that blockade of NO formation clearly decreased the slope of the autoregulation curve. The curves of the average data revealed a decrease in the lower limit of autoregulation. Although suggesting an improvement of RBF autoregulation, the data were not analyzed to that purpose (20). In contrast, several studies have failed to show involvement of NO on autoregulation. NOS inhibition in normotensive rats and dogs failed to affect RBF autoregulation (4,5). Majid et al. have published several reports on the autoregulatory behavior of the kidney during NO synthesis inhibition in dogs (2,3) and concluded that NO is not involved in the autoregulatory component of RBF regulation. Finally, there have been reports that inhibition of NO synthesis leads to decreased efficacy of autoregulation, suggesting that NO is important in the vasodilator arm of the autoregulatory response (21). Why these studies have yielded contrasting results is obscure; however, this could be due to species differences, experimental setup, and different activities of NO and AngII in the various settings. Taken together, these studies failed to show a consistent influence of NO on RBF autoregulation, and the findings of the present study do not support an important influence of NO on autoregulation in normotensive rats.
Despite these findings, there are indications that NO modulates autoregulation in various other tissues (7,8,9). In coronary (9) and mesenteric (8) vessels, it has been demonstrated that blockade of NO synthesis leads to extension of the autoregulatory range and to a decrease in the slope of the autoregulation curve, respectively. Studies in the brain are less conclusive, as one report indicated impaired (22), and another improved, autoregulation (7) of cerebral blood flow during NO synthesis inhibition. It is surprising that no important influence of NO on renal autoregualtion could be substantiated in normotensive rats. The renal vasculature is under strong influence of NO, as has been shown in many previous studies (1,2,3,4), and NOS has been detected in the endothelium (23) and in the macula densa (24). At a functional level, Imig et al. demonstrated that L-NNA administration improves adjustments of the afferent arteriole to decreases in perfusion pressure in the isolated-perfused juxtamedullary nephrons (25). In the isolated-perfused hydronephrotic kidney, Hayashi et al. found a left-shift of the relationship between RPP and afferent arteriolar diameter during L-NNA administration (26). Furthermore, experiments in our laboratory (10,27) and experiments by others (24,28) have shown that systemic, intraluminal, and peritubular administration of L-NNA leads to pronounced enhancements of TGF responsiveness. This body of data on both the myogenic response and the TGF mechanism, which both participate in renal autoregulation, supports that renal autoregulatory efficiency will be enhanced during NO synthesis inhibition. Nevertheless, only at the lower perfusion pressures could a significant increase in autoregulatory efficiency be demonstrated, and no change in lower limit of autoregulation was observed.
A new method was developed and applied to analyze the autoregulation curves, using nonlinear curve fitting to the logistic equation. Correlation coefficients were between 0.90 and 0.99. The sigmoidal curve has the mathematical characteristics of one inflection point and two shoulders, which can be found by differentiation. The lower limit of autoregulation was determined as that perfusion pressure at which the third derivative of the curve was 0. With this method, one can mathematically identify the shoulder of the autoregulation curve in a standardized manner. It substantially differs from the method employed by others, which uses the intersection of two straight lines drawn through the lower and the upper part of the autoregulation curve. This analysis of the lower limit of autoregulation could introduce substantial interobserver error (4). We evaluated the accuracy of this manual interpretation and found considerable scatter between the determination of the lower limit among the interpreters of the curves. Another method that has been used in several reports identifies the lower limit of autoregulation by finding the RPP value that decreases RBF by more than 0.2 ml/min per g kidney wt from baseline levels (29). It is obvious that in case of poor autoregulation, this method will incorrectly identify the lower limit. The main advantage of the newly developed strategy is that no arbitrary choices have to be made. In the present study, this new method was successfully applied and enabled the detection of a change in the autoregulatory behavior of the kidney in renovascular hypertensive rats.
The contralateral kidney of 2K1C renovascular hypertensive rats displayed impaired autoregulatory efficiency under baseline conditions. Enhanced production and systemic delivery of AngII by the ipsilateral kidney forms the underlying endocrine disturbance (14). The defect in autoregulation of the contralateral kidney is not compatible with increased actions of AngII (16). NO synthesis inhibition decreased the lower limit and increased the efficiency (as assessed by the degree of compensation) in these kidneys. Several studies support that the contralateral kidney of the 2K1C rat is under enhanced influence of NO. First, AngII can directly stimulate the expression of endothelial NOS (30). Furthermore, Beierwaltes et al. showed that increasing degrees of stenosis in the ipsilateral kidney in the 2K1C model was associated with increasing depression of RBF during application of systemic NO inhibition (12). Finally, we have recently reported that NO production and activity in the contralateral kidney is increased, assessed by use of an intrarenal NO clamp, as well as by measuring NO2/NO3 excretion (11). It is noted that in this study, NO dependency of the TGF systems was also studied. Maximum TGF responses displayed an exaggerated increase in response to proximal tubular infusion of L-NNA, indicating that the TGF system was dampened by enhanced influence of NO (11). The very high RVR in the contralateral kidney of the 2K1C rats compared with the kidneys of normotensive rats indicates a major influence of NO in the present study. Thus, the present study supports that enhanced NO activity serves to optimize RBF, while it decreases the efficiency of autoregulation and shifts the lower limit of autoregulation to a higher level of RPP.
Impaired autoregulation of RBF has been observed in various other models of hypertension, such as in the spontaneously hypertensive rat (31) and in the Dahl salt-sensitive rat (32). In the adult spontaneously hypertensive rat, the myogenic response is impaired (26) and the TGF responsiveness is high (33). The myogenic response improves upon application of NO synthesis inhibition (26). The TGF response, however, does not show enhanced NO dependency as in the 2K1C rat (33). The response of overall autoregulation of RBF to NO synthesis inhibition has not been studied to our knowledge. In the Dahl rat, the myogenic response is impaired (34) and the TGF system seems to react slightly more efficiently than in control rats (35). Systematic study has not been performed on the influence of NO on TGF, myogenic response, and overall autoregulation of RBF in the Dahl rat. The present study adds to a further characterization of RBF regulation in the 2K1C hypertensive model. It is now evident that the myogenic response of the afferent arteriole of the contralateral kidney is diminished (36), that TGF responsiveness is normal (11,18), and that overall autoregulation of RBF is diminished (37). NO activity is enhanced in this kidney (11), and importantly contributes to the maintenance of RBF (11,12). Blockade of NO synthesis improves efficiency of autoregulation and strongly enhances TGF responses (11). Thus, in contrast to the spontaneously hypertensive rat, NO is involved in both axes of the autoregulatory process. Additional studies should be aimed at determining the influence of hypertension per se and the influence of the primary pathophysiologic disturbance in these models.
A decrease in the lower limit and an increase in efficiency of RBF autoregulation, serve, under physiologic conditions, to better protect the kidney from fluctuations in RPP (38). The adaptation of the NO system in the contralateral kidney of renovascular hypertensive rats allows the kidney to increase blood flow upon further increases in RPP, i.e., upon further deterioration of systemic arterial pressure. In fact, NO synthesis inhibition unmasks the real actions of AngII on RBF auto-regulation: reduction of RBF at all perfusion pressures and stabilization of RBF upon changes in RBF, both at the lower end and at the upper end of prevailing perfusion pressures. The clinical relevance of the present findings is that intact endothelial function may relatively protect the contralateral kidney from sodium retention in renovascular hypertension. At present, it is unclear whether pharmacologic interventions improving endothelial dysfunction will lead to better control of arterial pressure in experimental or human renovascular hypertension.
In summary, the present study identified that in the nonclipped kidney of 2K1C hypertensive rats, the renal vasculature of the nonclipped kidney displays a high sensitivity to NO. Blockade of NO decreases the lower limit of autoregulation and increases the efficiency of RBF autoregulation. This change in autoregulatory behavior could be identified using a newly developed analytical method. The adaptive increase in NO activity in the contralateral kidney of the 2K1C rat may well protect the kidney from further increases in systemic arterial pressure.
| Appendix |
|---|
|
|
|---|
First derivative:
![]() |
Second derivative:
![]() |
Third derivative:
![]() |
In the case that f(x) = 1 +
eb(x-c), the sigmoidal curve, then
![]() |
and
![]() |
![]() |
Substituting yields:
![]() |
Replacing eb(x-c) by y
yields:
![]() |
By multiplying with (1 + y)4 and dividing by
b3 the equation is simplified to:
![]() |
Now find the values where k''' (x) = 0:
![]() |
Remember, y replaced
eb(x-c):
![]() |
Adding the other constants, a and d, in the logistic equation scales, the third derivative, however, does not influence value of x where the third derivative equals 0. Parameters for the logistic equation for each individual curve were calculated using a nonlinear curve fitting routine with SigmaPlot (Jandel Scientific®, Erkrath, Germany), and the result inspected in a graph. The lower limit of autoregulation was then calculated using the equation above. In the present study, this calculated value is used as the lower limit of autoregulation. An example of the application of this method is shown in Figure 1.
Using the first derivative of the logistic equation and the obtained
parameters, the slope of each individual curve was estimated at an RPP of 80,
90, 100, 110, 120 mmHg and, if possible, at 130, 140, 150, and 160 mmHg. The
first derivative of the logistic equation, as can be appreciated from the
outline above, is:
![]() |
The degree of compensation can then be calculated as follows:
![]() |
The degree of compensation should be interpreted as follows. If there is no autoregulation, the observed slope of the curve, k'(x), equals RBF(x)/MAP(x), so the degree of compensation is 0. If there is perfect autoregulation, the observed slope of the curve, k'(x), is 0, and the degree of autoregulation is 1.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. P. Koeners, B. Braam, D. M. van der Giezen, R. Goldschmeding, and J. A. Joles A perinatal nitric oxide donor increases renal vascular resistance and ameliorates hypertension and glomerular injury in adult fawn-hooded hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1847 - R1855. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, R. D. Loutzenhiser, and W. A. Cupples Frequency modulation of renal myogenic autoregulation by perfusion pressure Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1199 - R1204. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Cupples and B. Braam Assessment of renal autoregulation Am J Physiol Renal Physiol, April 1, 2007; 292(4): F1105 - F1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, C. Lau, and W. A. Cupples Interactive modulation of renal myogenic autoregulation by nitric oxide and endothelin acting through ET-B receptors Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2007; 292(1): R354 - R361. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Helle, O. B. Vagnes, and B. M. Iversen Angiotensin II-induced calcium signaling in the afferent arteriole from rats with two-kidney, one-clip hypertension Am J Physiol Renal Physiol, July 1, 2006; 291(1): F140 - F147. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Shi, X. Wang, K. H. Chon, and W. A. Cupples Tubuloglomerular feedback-dependent modulation of renal myogenic autoregulation by nitric oxide Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2006; 290(4): R982 - R991. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Just and W. J. Arendshorst Nitric oxide blunts myogenic autoregulation in rat renal but not skeletal muscle circulation via tubuloglomerular feedback J. Physiol., December 15, 2005; 569(3): 959 - 974. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Zhao, A. K. Cook, M. Field, B. Edwards, S. Zhang, Z. Zhang, J. S. Pollock, J. D. Imig, and E. W. Inscho Impaired Ca2+ Signaling Attenuates P2X Receptor-Mediated Vasoconstriction of Afferent Arterioles in Angiotensin II Hypertension Hypertension, September 1, 2005; 46(3): 562 - 568. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. S. A. Majid, A. Nishiyama, K. E. Jackson, and A. Castillo Superoxide scavenging attenuates renal responses to ANG II during nitric oxide synthase inhibition in anesthetized dogs Am J Physiol Renal Physiol, February 1, 2005; 288(2): F412 - F419. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Wronski, E. Seeliger, P. B. Persson, C. Forner, C. Fichtner, J. Scheller, and B. Flemming The step response: a method to characterize mechanisms of renal blood flow autoregulation Am J Physiol Renal Physiol, October 1, 2003; 285(4): F758 - F764. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sorensen, P. P. Leyssac, O. Skott, and N.-H. Holstein-Rathlou NO mediates downregulation of RBF after a prolonged reduction of renal perfusion pressure in SHR Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R329 - R338. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Racasan, J. A. Joles, P. Boer, H. A. Koomans, and B. Braam NO dependency of RBF and autoregulation in the spontaneously hypertensive rat Am J Physiol Renal Physiol, July 1, 2003; 285(1): F105 - F112. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. FLEMMING, N. ARENZ, E. SEELIGER, T. WRONSKI, K. STEER, and P. B. PERSSON Time-Dependent Autoregulation of Renal Blood Flow in Conscious Rats J. Am. Soc. Nephrol., November 1, 2001; 12(11): 2253 - 2262. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. K. A. WIEREMA, A. J. H. M. HOUBEN, A. A. KROON, D. KOSTER, K. V. D. ZANDER, J. M. A. V. ENGELSHOVEN, and P. W. D. LEEUW Nitric Oxide Dependence of Renal Blood Flow in Patients with Renal Artery Stenosis J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1836 - 1843. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. Dobrian, S. D. Schriver, and R. L. Prewitt Role of Angiotensin II and Free Radicals in Blood Pressure Regulation in a Rat Model of Renal Hypertension Hypertension, September 1, 2001; 38(3): 361 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kramp, P. Fourmanoir, and N. Caron Endothelin resets renal blood flow autoregulatory efficiency during acute blockade of NO in the rat Am J Physiol Renal Physiol, December 1, 2001; 281(6): F1132 - F1140. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. S. Pires, C. Julien, B. Chapuis, J. Sassard, and C. Barres Spontaneous renal blood flow autoregulation curves in conscious sinoaortic baroreceptor-denervated rats Am J Physiol Renal Physiol, January 1, 2002; 282(1): F51 - F58. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||